GSK Receives Positive Opinion For Conditional Approval Of New Oral Breast Cancer Treatment, Tyverb (lapatinib) GlaxoSmithKline (GSK) announced that the European
Medicines Agency's (EMEA) Committee for Medicinal Products for Human Use (CHMP) has issued a revised positive opinion confirming the positive benefit-risk profile for Tyverb� (lapatinib), GSK's new oral treatment for breast cancer. The positive opinion recommends grant of a conditional marketing authorisation.
Source: www.medicalnewstoday.comMonoclonal Antibody Hb3: A Marker For Colon Cancer Progression Or As A Therapeutic Target? There are a number of researchers who are searching for useful tumor markers to indicate cure. Antigens are being applied as an effective target in clinical therapy. Hb3 is an anti-colorectal cancer monoclonal antibody produced in the researchers' laboratory, and whose sensitivity and specificity are superior to that of anti-CEA.
Source: www.medicalnewstoday.com29% Of Men And 27% Of Women Experience Pain, USA More than a quarter of American men and women report feeling pain at any point in time, and those with lower incomes and less education spent more time in pain and had higher than average pain. These are the conclusions of authors of an Article published in this week's edition of The Lancet.Pain imposes considerable costs on the
health-care system and economy, and the occurrence of pain is a major reason for people seeing their doctor and taking medications.
Source: www.medicalnewstoday.comPreventative And Integrative Therapies UroToday.com A multimedia presentation was made at the recent Annual Meeting of the New York Section of the American Urological Association (AUA outlining the benefits of integrative and preventative therapies specifically in the treatment of bladder carcinoma.
Source: www.medicalnewstoday.comNew Weapon In Forensics Fingerprints that used to escape detection could soon help point to the killer. Using a field portable system being developed by ChemImage and Oak Ridge National Laboratory, investigators at crime scenes will be able to detect latent prints on human skin.The system takes advantage of surface-enhanced Raman spectroscopy (SERS)-based agents to visualize latent prints.
Source: www.medicalnewstoday.comA Patient Who Was Diagnosed As IPN-B Without Hepatolithiasis? Intraductal papillary neoplasm of the bile duct (IPN-B) is a neoplastic lesion preceding invasive intrahepatic cholangiocarcinoma (ICC) and is a new definition of a tumor with papillary growth in the intra- or extra-hepatic bile duct.
Source: www.medicalnewstoday.comFDA Approves Advair 250/50 For Reduction Of Exacerbations In Patients With COPD The U.S. Food and Drug Administration approved Advair Diskus 250/50 (fluticasone propionate 250 mcg and salmeterol 50 mcg inhalation powder) for the reduction of exacerbations in patients with chronic obstructive pulmonary disease (COPD) who have a history of exacerbations. With this approval, Advair becomes the only treatment FDA has approved to reduce COPD exacerbations.
Source: www.medicalnewstoday.comCommon Drugs Linked To Impaired Physical Function In Older Adults Older adults who take
drugs designed to block the neurotransmitter acetylcholine including common medications for incontinence, high blood pressure and allergies are more likely to be dependent in one or more activities of daily living and to walk slower, according to new findings from researchers at Wake Forest University School of
Medicine and colleagues.
Source: www.medicalnewstoday.comLabels: No Prescription, Online Pharmacy
# posted by Network @ 6:00 AM
